SlideShare a Scribd company logo
1 of 29
Iron Deficiency Anemia
Iron deficiency
• Neurocognitive effects
– developmental deficits: motoric, mental & cognitive
dysfunctio
– Pica
• Epithelial changes:
– GIT abnormalities, flattened & atrophic lingual
papillae,
– Koilonychia, dry skin
– angular stomatitis, glossitis
• Anemia
Intestinal iron absorption
• non-heme iron
• plants source: beans,
– dark green leafy vegetables
(spinach, kangkung)
– Fortified cereals, rice, enriched
whole-grain
– phytates /tannin, high gastric pH:
 absorption
– Ascorbic acid:  absorption
• heme iron >>
– Animal source: beef,
chicken, fish, cow’s milk
– More readily absorbed
Iron transport
Regulation of iron absorption and exportation by enterocytes.
Both heme and non-heme iron are absorbed by specific pathways, including
divalent metal transporter-1 (DMT-1) and heme carrier protein (HCP1), in
association with the ferrireductase, duodenal cytochrome B (Dcytb).
www.servier.fr/servier-medical-art).
Iron Requirements
• Infants & children
– <6 mo: 0.27 mg/day
– 7 mo - 1 year: 11 mg/day
– 1 - 3 years: 7 mg/day
– 4 - 8 years: 10 mg/day
Food and Nutrition Board at the Institute of Medicine
• Males
– 9 to 13 years: 8 mg/day
– 14 to 18 years: 11 mg/day
• Females
– 9 to 13 years: 8 mg/day
– 4 to 18 years: 15 mg/day
Epidemiology - IDA
SKRT 2001
• Infant 0-6 mo: 61,3%
• Infant 6-12 mo: 64,8%
• Toddler <5 yr: 48,1%.
SKRT 2007
• Toddler: 40-45%
USA, 2000
• Age 1-2 yr: 7 %
• Age 3-4 yr: 5%
Age %
12-59 mo 28,1
5-14 year 26,4
15-24 year 18,4
Riskesdas 2013
Etiology
 Increased demands
o Growth during infancy & childhood
o Treatment with erythropoiesis-stimulating agents
 Limited external supply
o Poor intake
o Inappropriate diet with deficit in bioavailable iron &/or ascorbic acid
o Malabsorption
 Gastric resection
 Helicobacter pylori infection (even without significant bleeding)
 Malabsorption syndromes (Crohn disease and coeliac disease)
o Drug interference (gastric anti-acid agents & antisecretory drugs)
 Increased losses
o Phlebotomy
o Haemorrhage: surgery, trauma, GIT /respiratory tract bleeding
Munoz, M.et al. (2011).. Journal of Clinical Pathology, 64, 287
Etiology
• Blood loss
– GASTROINTESTINAL BLOOD LOSS
• Epistaxis, Gastritis, Ulcer, Meckel’s diverticulum
• Milk-induced enteropathy
• Parasitosis, Varices, Tumor, polyps
• Inflammatory bowel disease
• Arteriovenous malformation
• Colonic diverticula
– VAGINAL BLOOD LOSS
• Increased menstrual flow, Tumor
– URINARY BLOOD LOSS
• Chronic infection, Tumor
– PULMONARY BLOOD LOSS
• Tuberculosis, Bronchiectasis
Anemia (WHO)
• 12-59 month Hb <11,0 g/dL
• 6-12 year Hb <12,0 g/dL
• Male ≥15 year Hb <13,0 g/dL
• Female 15-49 year Hb <12,0 g/dL.
Clinical manifestations
• nonspecific
• symptoms secondary to anemia.
– fatigue, lassitude, pallor, generalized lack of energy
– tachycardia, short breath, poor capillary refilling,
heart failure
• Symptoms secondary to iron deficiency
– Neurological effects
– Mental/psychological: pica,
– Epithelial defects: dry skin, koilonichia, brittle hair
Clinical manifestation
Rare
• Haemodynamic instability
• Syncope • Koilonychia
• Plummer-Vinson syndrome
Very frequent
• Pallor (45–50%)
• Fatigue (44%)
• Dyspnea (40%)
• Headache (63%)
Frequent
• Diffuse & moderate alopecia (30%)
• Atrophic glossitis (27%)
• Restless legs syndrome (24%)
• Dry & rough skin
• Dry & damaged hair
• Cardiac murmur (10%)
• Tachycardia (9%)
• Neurocognitive dysfunction
• Angina pectoris
• Vertigo
Glossitis
Stomatitis
angularis
Diagnosis
Stadium III: iron deficiency anemia
Stadium II
Iron deficiency
Stadium I:
Prelatent iron deficiency
Ferritin 
Serum iron 
TIBC , Sat.
transferrin 
CHr 
+
Hb  Ht 
MCV, MCH 
Labs
• Anemia: Hb , Ht 
• Blood smear
– Microcytic (low MCV)
– Hypochromic (low MCH)
– Pencil cell, target cell
– No hemolysis
https://i2.wp.com/www.stepwards.com/wp-
content/uploads/2016/01/4045_full.jpg
Hb (g/dL) Ht (%) MCV (fL)
Age (yr) Mean
Lower
Limit Mean
Lower
Limit Mean
Lower
Limit
0.5-1.9 12.5 11.0 37 33 77 70
2-4 12.5 11.0 38 34 79 73
5-7 13.0 11.5 39 35 81 75
8-11 13.5 12.0 40 36 83 76
12-14
Female 13.5 12.0 41 36 85 78
Male 14.0 12.5 43 37 84 77
15-17
Female 14.0 12.0 41 36 87 79
Male 15.0 13.0 46 38 86 78
Normal Mean & Lower Limits for Hb, Ht, MCV
Nathan and Oski’s Hematology of Infancy and Childhood 7th ed. 2009
Boy, 5 yr
Hb: 7,2 g/dL
Ht: 21,5 %
Leukosit: 6500/uL
Eritrosit: 2,9 juta/uL
Trombosit 210000/uL
MCV: 74 fL (78-98)
MCH: 22 pg (25-35)
MCHC: 30 g/dL (31-37)
MCV: {Ht/RBC} x 10
MCH: {Hb/RBC} x 10
Labs
• Iron status
– serum iron 
– transferrin saturation
– TIBC 
– Ferritin 
– sTfr 
Low erythropoiesis
• Reticulocyte 
• CHr 
https://courses.washington.edu/conj/bess/iron/ironfig.png
Algorithm diagnosis
(modified from Weiss and Goodnough
(2005)
soluble form of transferrin
receptor (sTfR): total amount of
cell surface transferrin receptors
: IDA
: low erythroid progenitor
Treatment
1. Iron therapy
– Oral
– intravenous
2. Causal treatment
Treatment
Iron therapy
1. Elemental iron 4-6 mg/kg/day
– Empty stomach
– High iron dietary uptake
– Avoid tea, coffee, antacid, H2 antihistamine
blocker, proton pump inhibitor
2. Ascorbic acid supplementation
3. Folic acid supplementation (female teenager)
4. Treat the primary illness
• Iron preparation
– Ferrous sulfate (20% elemental iron)
– Ferrous gluconate (15% elemental iron)
– Elemental iron
• Continue therapy 2 months after anemia
resolved : iron storage
Parenteral iron therapy
Indications:
• oral iron is poorly tolerated;
• rapid replacement of iron stores is needed;
• gastrointestinal iron absorption is
compromised;
• erythropoietin therapy is necessary,
particularly in renal dialysis patients.
Am Fam Physician. 2013 Jan 15;87(2):98-104.
Treatment failure
• Noncompliance
• Insufficient dose / duration of therapy
• Inhibitors of iron absorption/utilization
– Antacids, Histamine H2 blockers, proton pump inhibitors
– Lead, aluminum intoxication (hemodialysis patients)
– Chronic inflammation, Neoplasia
• Primary illness??? Ongoing blood loss
• Incorrect diagnosis
– Thalassemia disorder, anemia of chronic disease
REKOMENDASI IDAI
tentang Suplementasi Besi untuk Bayi dan Anak
Suplementasi besi diberikan kepada semua
anak, dengan prioritas usia balita (0-5 tahun),
terutama usia 0-2 tahun.
REKOMENDASI IDAI
–BBLR (<2500 g): 3 mg/kgBB/hari untuk usia 1
bl-2 th (dosis max 15 mg/hari, dosis tunggal).
–Bayi cukup bulan: 2 mg/kgBB/hari usia 4 bl-2 th
–Usia 2-12 tahun (usia sekolah): 1
mg/kgBB/hari, 2x/minggu selama 3 bl
berturut-turut/thn
–Usia 12-18 th (remaja): 60 mg/hari atau 1
mg/kgBB/hari, 2x/mgg selama 3 bl berturut-
turut/th (remaja perempuan + 400 µg asam
folat).
Take home messages
• Check any risk of iron deficiency
– Diet history, risk factors
– Good clinical exams
• Supplementation (rekomendasi IDAI)

More Related Content

Similar to ADB.pptx

a child with anaemia - an approach
a child with anaemia - an approacha child with anaemia - an approach
a child with anaemia - an approachViraj Satenahalli
 
Iron deficiency
Iron deficiencyIron deficiency
Iron deficiencyethan
 
epidemiology anemia 2015 epidemiology.ppt
epidemiology anemia 2015 epidemiology.pptepidemiology anemia 2015 epidemiology.ppt
epidemiology anemia 2015 epidemiology.pptayupamilih
 
anemia by dr betelehem tefera
anemia by dr betelehem teferaanemia by dr betelehem tefera
anemia by dr betelehem teferaBetelehem Tefera
 
Iron Deficiency Anemia/Dr. Youssef Quda
Iron Deficiency Anemia/Dr. Youssef QudaIron Deficiency Anemia/Dr. Youssef Quda
Iron Deficiency Anemia/Dr. Youssef QudaDryoussef Koda
 
2 microcytic anemia i-iron deficiency.ppt
2 microcytic anemia i-iron deficiency.ppt2 microcytic anemia i-iron deficiency.ppt
2 microcytic anemia i-iron deficiency.pptAbdulKaderSouid
 
Anaemia
AnaemiaAnaemia
Anaemiameear
 
Approach to the_child_with_anemia
Approach to the_child_with_anemiaApproach to the_child_with_anemia
Approach to the_child_with_anemiaVivek Verma
 
Iron deficiency anemia final
Iron deficiency anemia finalIron deficiency anemia final
Iron deficiency anemia finalBhageerath Reddy
 
Iron deficiency anemia 29.12.21
Iron deficiency anemia 29.12.21Iron deficiency anemia 29.12.21
Iron deficiency anemia 29.12.21Aakriti Dhiman
 
Causes of Anemia in childhood, etiology investigation and mangement
Causes of Anemia in childhood, etiology investigation and mangementCauses of Anemia in childhood, etiology investigation and mangement
Causes of Anemia in childhood, etiology investigation and mangementMariamMahmoud73
 
anemia_in_children.pdf
anemia_in_children.pdfanemia_in_children.pdf
anemia_in_children.pdfHrithik70959
 
ANEMIA PPT-1.pptx ......................
ANEMIA PPT-1.pptx ......................ANEMIA PPT-1.pptx ......................
ANEMIA PPT-1.pptx ......................Priya982187
 

Similar to ADB.pptx (20)

a child with anaemia - an approach
a child with anaemia - an approacha child with anaemia - an approach
a child with anaemia - an approach
 
Anemia Panel - New.pptx
Anemia Panel - New.pptxAnemia Panel - New.pptx
Anemia Panel - New.pptx
 
Aproach to anemia
Aproach to anemiaAproach to anemia
Aproach to anemia
 
Aproach to anemia
Aproach to anemiaAproach to anemia
Aproach to anemia
 
Iron deficiency anemia
Iron deficiency anemiaIron deficiency anemia
Iron deficiency anemia
 
Iron deficiency
Iron deficiencyIron deficiency
Iron deficiency
 
epidemiology anemia 2015 epidemiology.ppt
epidemiology anemia 2015 epidemiology.pptepidemiology anemia 2015 epidemiology.ppt
epidemiology anemia 2015 epidemiology.ppt
 
anemia by dr betelehem tefera
anemia by dr betelehem teferaanemia by dr betelehem tefera
anemia by dr betelehem tefera
 
Iron Deficiency Anemia/Dr. Youssef Quda
Iron Deficiency Anemia/Dr. Youssef QudaIron Deficiency Anemia/Dr. Youssef Quda
Iron Deficiency Anemia/Dr. Youssef Quda
 
RBC DISORDERS.ppt
RBC DISORDERS.pptRBC DISORDERS.ppt
RBC DISORDERS.ppt
 
2 microcytic anemia i-iron deficiency.ppt
2 microcytic anemia i-iron deficiency.ppt2 microcytic anemia i-iron deficiency.ppt
2 microcytic anemia i-iron deficiency.ppt
 
Iron
IronIron
Iron
 
Anaemia
AnaemiaAnaemia
Anaemia
 
Approach to the_child_with_anemia
Approach to the_child_with_anemiaApproach to the_child_with_anemia
Approach to the_child_with_anemia
 
REVIEW OF ANEMIA
REVIEW OF ANEMIAREVIEW OF ANEMIA
REVIEW OF ANEMIA
 
Iron deficiency anemia final
Iron deficiency anemia finalIron deficiency anemia final
Iron deficiency anemia final
 
Iron deficiency anemia 29.12.21
Iron deficiency anemia 29.12.21Iron deficiency anemia 29.12.21
Iron deficiency anemia 29.12.21
 
Causes of Anemia in childhood, etiology investigation and mangement
Causes of Anemia in childhood, etiology investigation and mangementCauses of Anemia in childhood, etiology investigation and mangement
Causes of Anemia in childhood, etiology investigation and mangement
 
anemia_in_children.pdf
anemia_in_children.pdfanemia_in_children.pdf
anemia_in_children.pdf
 
ANEMIA PPT-1.pptx ......................
ANEMIA PPT-1.pptx ......................ANEMIA PPT-1.pptx ......................
ANEMIA PPT-1.pptx ......................
 

Recently uploaded

Energy Resources. ( B. Pharmacy, 1st Year, Sem-II) Natural Resources
Energy Resources. ( B. Pharmacy, 1st Year, Sem-II) Natural ResourcesEnergy Resources. ( B. Pharmacy, 1st Year, Sem-II) Natural Resources
Energy Resources. ( B. Pharmacy, 1st Year, Sem-II) Natural ResourcesShubhangi Sonawane
 
Unit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxUnit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxVishalSingh1417
 
Class 11th Physics NEET formula sheet pdf
Class 11th Physics NEET formula sheet pdfClass 11th Physics NEET formula sheet pdf
Class 11th Physics NEET formula sheet pdfAyushMahapatra5
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdfQucHHunhnh
 
Application orientated numerical on hev.ppt
Application orientated numerical on hev.pptApplication orientated numerical on hev.ppt
Application orientated numerical on hev.pptRamjanShidvankar
 
Micro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdfMicro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdfPoh-Sun Goh
 
This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.christianmathematics
 
microwave assisted reaction. General introduction
microwave assisted reaction. General introductionmicrowave assisted reaction. General introduction
microwave assisted reaction. General introductionMaksud Ahmed
 
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...Shubhangi Sonawane
 
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptxMaritesTamaniVerdade
 
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...Nguyen Thanh Tu Collection
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfagholdier
 
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...EduSkills OECD
 
Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104misteraugie
 
Z Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot GraphZ Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot GraphThiyagu K
 
Key note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfKey note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfAdmir Softic
 
psychiatric nursing HISTORY COLLECTION .docx
psychiatric  nursing HISTORY  COLLECTION  .docxpsychiatric  nursing HISTORY  COLLECTION  .docx
psychiatric nursing HISTORY COLLECTION .docxPoojaSen20
 
Unit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptxUnit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptxVishalSingh1417
 

Recently uploaded (20)

Energy Resources. ( B. Pharmacy, 1st Year, Sem-II) Natural Resources
Energy Resources. ( B. Pharmacy, 1st Year, Sem-II) Natural ResourcesEnergy Resources. ( B. Pharmacy, 1st Year, Sem-II) Natural Resources
Energy Resources. ( B. Pharmacy, 1st Year, Sem-II) Natural Resources
 
Unit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxUnit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptx
 
Class 11th Physics NEET formula sheet pdf
Class 11th Physics NEET formula sheet pdfClass 11th Physics NEET formula sheet pdf
Class 11th Physics NEET formula sheet pdf
 
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptxINDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdf
 
Application orientated numerical on hev.ppt
Application orientated numerical on hev.pptApplication orientated numerical on hev.ppt
Application orientated numerical on hev.ppt
 
Micro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdfMicro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdf
 
This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.
 
microwave assisted reaction. General introduction
microwave assisted reaction. General introductionmicrowave assisted reaction. General introduction
microwave assisted reaction. General introduction
 
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
 
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
 
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdf
 
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
 
Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104
 
Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024
 
Z Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot GraphZ Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot Graph
 
Key note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfKey note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdf
 
psychiatric nursing HISTORY COLLECTION .docx
psychiatric  nursing HISTORY  COLLECTION  .docxpsychiatric  nursing HISTORY  COLLECTION  .docx
psychiatric nursing HISTORY COLLECTION .docx
 
Unit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptxUnit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptx
 

ADB.pptx

  • 2.
  • 3. Iron deficiency • Neurocognitive effects – developmental deficits: motoric, mental & cognitive dysfunctio – Pica • Epithelial changes: – GIT abnormalities, flattened & atrophic lingual papillae, – Koilonychia, dry skin – angular stomatitis, glossitis • Anemia
  • 4. Intestinal iron absorption • non-heme iron • plants source: beans, – dark green leafy vegetables (spinach, kangkung) – Fortified cereals, rice, enriched whole-grain – phytates /tannin, high gastric pH:  absorption – Ascorbic acid:  absorption • heme iron >> – Animal source: beef, chicken, fish, cow’s milk – More readily absorbed
  • 5. Iron transport Regulation of iron absorption and exportation by enterocytes. Both heme and non-heme iron are absorbed by specific pathways, including divalent metal transporter-1 (DMT-1) and heme carrier protein (HCP1), in association with the ferrireductase, duodenal cytochrome B (Dcytb). www.servier.fr/servier-medical-art).
  • 6. Iron Requirements • Infants & children – <6 mo: 0.27 mg/day – 7 mo - 1 year: 11 mg/day – 1 - 3 years: 7 mg/day – 4 - 8 years: 10 mg/day Food and Nutrition Board at the Institute of Medicine • Males – 9 to 13 years: 8 mg/day – 14 to 18 years: 11 mg/day • Females – 9 to 13 years: 8 mg/day – 4 to 18 years: 15 mg/day
  • 7. Epidemiology - IDA SKRT 2001 • Infant 0-6 mo: 61,3% • Infant 6-12 mo: 64,8% • Toddler <5 yr: 48,1%. SKRT 2007 • Toddler: 40-45% USA, 2000 • Age 1-2 yr: 7 % • Age 3-4 yr: 5% Age % 12-59 mo 28,1 5-14 year 26,4 15-24 year 18,4 Riskesdas 2013
  • 8. Etiology  Increased demands o Growth during infancy & childhood o Treatment with erythropoiesis-stimulating agents  Limited external supply o Poor intake o Inappropriate diet with deficit in bioavailable iron &/or ascorbic acid o Malabsorption  Gastric resection  Helicobacter pylori infection (even without significant bleeding)  Malabsorption syndromes (Crohn disease and coeliac disease) o Drug interference (gastric anti-acid agents & antisecretory drugs)  Increased losses o Phlebotomy o Haemorrhage: surgery, trauma, GIT /respiratory tract bleeding Munoz, M.et al. (2011).. Journal of Clinical Pathology, 64, 287
  • 9. Etiology • Blood loss – GASTROINTESTINAL BLOOD LOSS • Epistaxis, Gastritis, Ulcer, Meckel’s diverticulum • Milk-induced enteropathy • Parasitosis, Varices, Tumor, polyps • Inflammatory bowel disease • Arteriovenous malformation • Colonic diverticula – VAGINAL BLOOD LOSS • Increased menstrual flow, Tumor – URINARY BLOOD LOSS • Chronic infection, Tumor – PULMONARY BLOOD LOSS • Tuberculosis, Bronchiectasis
  • 10. Anemia (WHO) • 12-59 month Hb <11,0 g/dL • 6-12 year Hb <12,0 g/dL • Male ≥15 year Hb <13,0 g/dL • Female 15-49 year Hb <12,0 g/dL.
  • 11. Clinical manifestations • nonspecific • symptoms secondary to anemia. – fatigue, lassitude, pallor, generalized lack of energy – tachycardia, short breath, poor capillary refilling, heart failure • Symptoms secondary to iron deficiency – Neurological effects – Mental/psychological: pica, – Epithelial defects: dry skin, koilonichia, brittle hair
  • 12. Clinical manifestation Rare • Haemodynamic instability • Syncope • Koilonychia • Plummer-Vinson syndrome Very frequent • Pallor (45–50%) • Fatigue (44%) • Dyspnea (40%) • Headache (63%) Frequent • Diffuse & moderate alopecia (30%) • Atrophic glossitis (27%) • Restless legs syndrome (24%) • Dry & rough skin • Dry & damaged hair • Cardiac murmur (10%) • Tachycardia (9%) • Neurocognitive dysfunction • Angina pectoris • Vertigo
  • 14.
  • 15. Diagnosis Stadium III: iron deficiency anemia Stadium II Iron deficiency Stadium I: Prelatent iron deficiency Ferritin  Serum iron  TIBC , Sat. transferrin  CHr  + Hb  Ht  MCV, MCH 
  • 16. Labs • Anemia: Hb , Ht  • Blood smear – Microcytic (low MCV) – Hypochromic (low MCH) – Pencil cell, target cell – No hemolysis https://i2.wp.com/www.stepwards.com/wp- content/uploads/2016/01/4045_full.jpg
  • 17. Hb (g/dL) Ht (%) MCV (fL) Age (yr) Mean Lower Limit Mean Lower Limit Mean Lower Limit 0.5-1.9 12.5 11.0 37 33 77 70 2-4 12.5 11.0 38 34 79 73 5-7 13.0 11.5 39 35 81 75 8-11 13.5 12.0 40 36 83 76 12-14 Female 13.5 12.0 41 36 85 78 Male 14.0 12.5 43 37 84 77 15-17 Female 14.0 12.0 41 36 87 79 Male 15.0 13.0 46 38 86 78 Normal Mean & Lower Limits for Hb, Ht, MCV Nathan and Oski’s Hematology of Infancy and Childhood 7th ed. 2009
  • 18. Boy, 5 yr Hb: 7,2 g/dL Ht: 21,5 % Leukosit: 6500/uL Eritrosit: 2,9 juta/uL Trombosit 210000/uL MCV: 74 fL (78-98) MCH: 22 pg (25-35) MCHC: 30 g/dL (31-37) MCV: {Ht/RBC} x 10 MCH: {Hb/RBC} x 10
  • 19. Labs • Iron status – serum iron  – transferrin saturation – TIBC  – Ferritin  – sTfr  Low erythropoiesis • Reticulocyte  • CHr  https://courses.washington.edu/conj/bess/iron/ironfig.png
  • 20. Algorithm diagnosis (modified from Weiss and Goodnough (2005) soluble form of transferrin receptor (sTfR): total amount of cell surface transferrin receptors : IDA : low erythroid progenitor
  • 21. Treatment 1. Iron therapy – Oral – intravenous 2. Causal treatment
  • 22. Treatment Iron therapy 1. Elemental iron 4-6 mg/kg/day – Empty stomach – High iron dietary uptake – Avoid tea, coffee, antacid, H2 antihistamine blocker, proton pump inhibitor 2. Ascorbic acid supplementation 3. Folic acid supplementation (female teenager) 4. Treat the primary illness
  • 23. • Iron preparation – Ferrous sulfate (20% elemental iron) – Ferrous gluconate (15% elemental iron) – Elemental iron • Continue therapy 2 months after anemia resolved : iron storage
  • 24. Parenteral iron therapy Indications: • oral iron is poorly tolerated; • rapid replacement of iron stores is needed; • gastrointestinal iron absorption is compromised; • erythropoietin therapy is necessary, particularly in renal dialysis patients.
  • 25. Am Fam Physician. 2013 Jan 15;87(2):98-104.
  • 26. Treatment failure • Noncompliance • Insufficient dose / duration of therapy • Inhibitors of iron absorption/utilization – Antacids, Histamine H2 blockers, proton pump inhibitors – Lead, aluminum intoxication (hemodialysis patients) – Chronic inflammation, Neoplasia • Primary illness??? Ongoing blood loss • Incorrect diagnosis – Thalassemia disorder, anemia of chronic disease
  • 27. REKOMENDASI IDAI tentang Suplementasi Besi untuk Bayi dan Anak Suplementasi besi diberikan kepada semua anak, dengan prioritas usia balita (0-5 tahun), terutama usia 0-2 tahun.
  • 28. REKOMENDASI IDAI –BBLR (<2500 g): 3 mg/kgBB/hari untuk usia 1 bl-2 th (dosis max 15 mg/hari, dosis tunggal). –Bayi cukup bulan: 2 mg/kgBB/hari usia 4 bl-2 th –Usia 2-12 tahun (usia sekolah): 1 mg/kgBB/hari, 2x/minggu selama 3 bl berturut-turut/thn –Usia 12-18 th (remaja): 60 mg/hari atau 1 mg/kgBB/hari, 2x/mgg selama 3 bl berturut- turut/th (remaja perempuan + 400 µg asam folat).
  • 29. Take home messages • Check any risk of iron deficiency – Diet history, risk factors – Good clinical exams • Supplementation (rekomendasi IDAI)

Editor's Notes

  1. Regulation of iron absorption and exportation by enterocytes. Both heme and non-heme iron are absorbed by specific pathways, including divalent metal transporter-1 (DMT-1) and heme carrier protein (HCP1), in association with the ferrireductase, duodenal cytochrome B (Dcytb). Within the cell, iron can be stored within the ferritin molecule. The metal is exported by the protein ferroportin (FPN1), and transported into the blood by transferrin. In presence of hepcidin, ferroportin is internalized and degradated. Thus, iron exportation is blocked. Inversely, in the absence of hepcidin, ferroportin is maintained on the cell membrane, and iron transportation is facilitated (illustrations used elements from Servier Medical Art: www.servier.fr/servier-medical-art).